P1

Regional Early-Stage Venture Capital · Private Equity, VC & Investor

P101

Italian venture capital manager backing early-to-growth technology companies.

Available information varies by company and source.

Profile record updated:

Company facts

Official name
P101 SGR S.p.A.
Entity type
COMPANY
Headquarters
Italy
Company size
10–49
Market cluster / sector
Regional Early-Stage Venture Capital
Market role
Private Equity, VC & Investor
Official website
p101.it

What P101 does

The company operates a venture capital asset management model. It raises closed-end investment funds and managed mandates, allocates capital into technology businesses, supports portfolio development, and seeks returns through exits and valuation growth. Revenue is generated by managing third-party capital over multi-year fund lives and sharing in investment upside when portfolio companies realise gains.

Category differentiation

This company is a venture capital fund manager, not an operating software vendor or advertising platform. It should not be confused with portfolio companies, fund brand names, or Azimut Holding itself.

Strategic context

AI-supported assessment from the existing company research; distinguish interpretation from sourced facts.

P101 SGR S.p.A. is an Italian venture capital fund manager focused on digital and technology companies from early to growth stage. It manages multiple funds, including Programma 103 and Italia 500 under mandate, and reported €500 million in assets under management on its website. The business is headquartered in Milan and operates as an active investment platform with a regulated fund-management profile. The company creates value by raising capital from limited partners, deploying that capital into venture-backed technology companies, and supporting portfolio growth through network, governance, and follow-on financing. Its customers are institutional and qualified investors allocating to venture capital, alongside founders and management teams seeking equity capital and strategic support. Revenue is driven primarily by recurring fund management fees and performance-based carried interest, with additional mandate-related management economics where applicable.

Company news briefing

Briefing updated:

P101 continues to support portfolio growth, recently leading a €5.2 million funding round for Biorsaf alongside its acquisition of Cooki to establish a prominent Food RegTech platform. Additionally, the venture capital manager led a €4.3 million funding round in deeptech startup Agora Labs to expand its clinical data infrastructure, whilst integrating PranaVentures and executing portfolio exits such as Cyber Guru.

Business model & monetisation

P101 monetises through recurring management fees on assets under management, performance-based carried interest on successful exits, and mandate management fees for vehicles managed on behalf of external capital providers. Its commercial model is not software subscription-based; it is an asset management and investment performance model tied to fund size, duration, and realised portfolio returns.

Fund management fees
Service Fee
Carried interest
Percentage Take-Rate
Mandate management fees
Service Fee

Products & capabilities

No products with linked sources are available in this view.

Polaris7 Intelligence

Unlock Full Intelligence Profile for P101

Get unlimited access to corporate ownership, historical M&A transactions, verified tech stack telemetry, and live market signals in the interactive Knowledge Graph.

Verified Ownership & Corporate Hierarchy

Complete corporate hierarchy traversal, shareholder cap table history, and parent holding links sourced from regulatory filings.

360° Tech Stack & Vendor Telemetry

Technical header bidding configurations, sellers.json registry nodes, CMP disclosures, and direct programmatic supply chains.

Live Market Signals & Executive Briefings

Continuous 24/7 monitoring of material M&A deals, executive shifts, product rollouts, and hiring trends across peer entities.

Verified primary sourcesContinuous signal monitoring1-click Google/LinkedIn
Unlock Full Intelligence Profile

Competitors & alternatives

Track competitor shifts

Receive automated telemetry on strategic moves, acquisitions, and market share shifts across P101's competitive landscape.

Monitor company

Recent recorded signals

Dates refer to the source publication. Older entries are historical context, not evidence of a new event.

  • Agora Labs Raises €4.3M to Expand Clinical Data Infrastructure

    tech.eu

    Funding · Recorded impact score: 1/5

    Italian deeptech startup Agora Labs has raised €4.3 million in a funding round led by venture capital firm P101 SGR, with participation from the Mussetto family, owners of Infinite Five, a holding company focused on marketing technology, data analysis and robotics. The company develops technology that enables hospitals to make clinical data available for medical and scientific research while protecting patient privacy. Agora Labs installs dedicated computing nodes at healthcare facilities using GPUs from NVIDIA and specialized large language models to structure and standardize data, with anonymization processes protecting patient information. Through federated AI, the infrastructure connects hospitals, allowing research centers and pharmaceutical companies to conduct studies without directly accessing patient records. The funding will help Agora Labs strengthen its presence in Europe and the US and expand into the Middle East and India, as well as recruit around 20 technical and commercial professionals.

    • Agora Labs raised €4.3 million in a funding round led by P101 SGR.
    • The Mussetto family, owners of Infinite Five, participated in the round.
  • P101 leads €4.3 million round in Agora Labs, the Italian deeptech company serving global healthcare

    p101.it

    M&A & Corporate Finance · Recorded impact score: 2/5

    Italian venture capital firm P101 has led a €4.3 million investment round in Agora Labs, an Italian deep tech company specializing in privacy-preserving clinical data infrastructure for healthcare research. The round also included participation from the Mussetto family through holding company Infinite Five. Agora Labs plans to use the capital to double its partner hospital network to 100 facilities, hire approximately 20 technical and commercial staff, and expand operations across Europe, the US, the Middle East, and India.

    • P101 SGR led the €4.3 million funding round with participation from Infinite Five (Mussetto family).
    • Agora Labs currently connects 50 healthcare institutions, including Harvard Medical School and San Raffaele Hospital in Milan, targeting 100 in the coming months.
  • Toduba acquires BitQ: a new super player emerges in corporate welfare

    p101.it

    Product & Platform Launch · Recorded impact score: 4/5

    P101 leads Biorsaf’s €5.2 million funding round as the company acquires Cooki to create Italy’s leading Food RegTech platform

  • P101 leads Biorsaf’s €5.2 million funding round as the company acquires Cooki to create Italy’s leading Food RegTech platform

    3 SourcesP101·P101·P101

    M&A & Corporate Finance · Recorded impact score: 3.5/5

    P101 SGR led a €5.2 million funding round in Biorsaf, Italy's leading food safety and quality digitisation company. Biorsaf also acquired Cooki, a food information management platform, creating Italy's first unified Food RegTech platform. The capital will support a three-year growth plan focused on AI and expanding the workforce from 40 to 120 employees. The target market comprises around 3.4 million businesses generating over €12 billion in revenue, with digitisation penetration of only 3%.

    • P101 SGR led a €5.2 million funding round in Biorsaf, announced on September 10, 2026.
    • Biorsaf acquired Cooki, a platform founded in 2017 active in more than 450 Italian cities with over 1,000 users and a database of 35,000 coded products.

Explore company relationships

Questions about P101

What is P101?

P101 is an Italian venture capital fund manager investing in digital and technology companies across early to growth stages.

Who uses P101?

P101 serves limited partners and qualified investors seeking venture exposure, and founders seeking equity capital and strategic support.

How does P101 make money?

P101 earns management fees on assets under management and carried interest on successful investment exits, plus mandate-related fees where applicable.

Sources & coverage

This profile uses public, official and technically observable information. Missing information does not prove that a product or relationship does not exist. The list below does not imply that every profile statement has been verified.

4 publicly documented primary sources and citations linked across the market graph.

Continue your research on P101

Open additional company details, personal Watchlists and your Strategic Intelligence Agent in Polaris7. It monitors your market daily and delivers tailored briefings with clear strategic context whenever relevant news occurs.

Daily intelligent monitoring · Verified primary sources.